INQUINOA (CONICET), San Miguel de Tucumán, Tucumán, Argentina.
Phytother Res. 2012 Nov;26(11):1759-67. doi: 10.1002/ptr.4633. Epub 2012 Mar 26.
The antimicrobial and antioxidant activities of standardized extracts of Baccharis incarum in 60° and 80° ethanol and of a phytopharmaceutical formulation obtained from them were measured. Baccharis tinctures showed antimicrobial activity against clinically isolated antibiotic resistant Staphylococcus aureus and Enterococcus faecalis, with MIC values of 40-80 µg GAE/mL. Both tinctures exhibited ABTS(●+) scavenging activity with SC(50) values between 1.6 and 4.0 µg GAE/mL. The tinctures were not genotoxic in the Salmonella assay. For this reason, the tincture in 60° ethanol was incorporated into a topical pharmaceutical formulation (Hydrogel/ Carbopol® 934). The phytopharmaceutical formulation also showed antibacterial and antioxidant activities in the in vitro assays. The hydrogel showed microbiological, chemical, physical and functional stability during storage at room temperature. Studies that measure drug release as a determination of bioavailability were also carried out using the Franz diffusion cell (FC). The results demonstrated the release of two bioactive compounds (chlorogenic acid and 4',5-dihydroxy-3',3,6,7,8-pentamethoxyflavone) from the phytotherapic preparation in HPLC studies of FC receptor solution. In consequence, the phytopreparation applied topically could be used to treat skin and soft tissue infection produced by methicillin-resistant Staphylococcus aureus (MRSA) or Enterococcus faecalis and opens new opportunities for the use of active natural ingredients in the cosmeceutical field as antiacne and antioxidant.
测定了 Baccharis incarum 的 60°和 80°乙醇标准化提取物以及从中获得的植物药制剂的抗菌和抗氧化活性。 Baccharis 酊剂对临床分离的耐抗生素金黄色葡萄球菌和粪肠球菌具有抗菌活性,MIC 值为 40-80μg GAE/mL。两种酊剂均具有 ABTS(●+)清除活性,SC(50)值在 1.6 至 4.0μg GAE/mL 之间。酊剂在沙门氏菌试验中没有遗传毒性。因此,60°乙醇中的酊剂被纳入一种局部药物制剂(Hydrogel/Carbopol®934)。植物药制剂在体外试验中也表现出抗菌和抗氧化活性。在室温下储存期间,水凝胶显示出微生物学、化学、物理和功能稳定性。还使用 Franz 扩散池(FC)进行了释放测定生物利用度的药物释放研究。结果表明,在 FC 受体溶液的 HPLC 研究中,从植物治疗制剂中释放出两种生物活性化合物(绿原酸和 4',5-二羟基-3',3,6,7,8-五甲氧基黄酮)。因此,局部应用的植物制剂可用于治疗耐甲氧西林金黄色葡萄球菌(MRSA)或粪肠球菌引起的皮肤和软组织感染,并为在化妆品领域使用活性天然成分提供了新的机会,例如抗粉刺和抗氧化。